Journal Articles
Raynaud K, Seguy D, Rogosnitzky M, Saulnier F, Pruvot FR, Zerbib Ph.
Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome
Langebecks Arch Surg,
2016
;401(1):81-7.
[PubMed]
Rogosnitzky M. and Branch S.
Gadolinium-Based Contrast Agent Toxicity- A Review of Known and Proposed Mechanisms
BioMetals,
2016
;29(3), 365-376.
[PubMed] [Full Article]
Rogosnitzky Moshe, Isakov Itzhak, Wlassoff Wjatschesslaw, Ingram April, and Barishak Y. Robert.
Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
Journal of Ocular Pharmacology and Therapeutics,
2015
;32(2):83-9.
[PubMed] [Full Article]
Bauters A, Rogosnitzky M, Hachulla E, Copin MC, Saudemont A, Zerbib P
Elevated Plasma Fibrinogen in Clinically Asymptomatic Unicentric Castleman's Disease: A Case Report.
J Clin Exp Hematop,
2014
;54(1):85-8.
[PubMed] [Full Article]
Zerbib P, Vinet A, Rogosnitzky M, Truant S, Chambon JP, Pruvot FR.
Gastrocele Complicates the Course of Non-operated Severe Caustic Injuries: Operative Strategies.
World J. Surg,
2014
;38(5): 1233-7.
[PubMed]
Dalgleish A, Featherstone P, Vlassov V, Rogosnitzky M.
Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.
Invest New Drugs,
2014
[PubMed]
Carlock BH, Bienstock CA, Rogosnitzky M.
Pterygium: nonsurgical treatment using topical dipyrdiamole - a case report.
Case Rep Ophthalmol,
2014
;5(1):98-103.
[PubMed] [Full Article]
A Bauters, DJ Holt, P Zerbib, M Rogosnitzky.
Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect?
Biometals,
2013
[PubMed]
Lebas A, Rogosnitzky M, Chater C, Colombel JF, Nachury M, Cortot A, and Zerbib Ph.
Efficacy of sacral nerve stimulation for poor functional results of J-Pouch ileoanal anastomosis: a pilot study.
Techniques in Coloproctology,
2013
[PubMed]
Ph Zerbib, R Caiazzo, G Piessen, M Rogosnitzky, C Séquier, D Koriche, S Truant, E Boleslawski, J-P Chambon, F Pruvot.
Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects – a prospective study.
2013
[PubMed]
Rogosnitzky M, Danks R, Holt D.
Intravenous Immunoglobulin for the treatment of Crohn's disease (review).
Autoimmunity Reviews,
2012
[PubMed] [Full Article]
Rogosnitzky M, Danks R, Kardash E.
Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders (review).
Anticancer Res,
2012
;32(7): 2471- 2478.
[PubMed] [Full Article]
Rogosnitzky M, Finegold MJ, McLauglin PJ, Zagon IS.
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.
Invest New Drugs,
2012
[PubMed]
Rogosnitzky M, Danks R.
The therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions (review).
Pharmacological Reports,
2011
;63, 337-347.
[PubMed] [Full Article]
Goodley PH, Rogosnitzky M.
The Effect of Gallium Nitrate on Arresting Blood Flow from a Wound.
Case Reports in Medicine,
2011
;Article ID 819710.
[PubMed] [Full Article]
Barken I, Geller J, Rogosnitzky M.
Prophylactic noscapine inhibits prostate cancer in a mouse model.
Anticancer Res,
2010
;30(2):399-401.
[PubMed] [Full Article]
Rogosnitzky M, Danks R
Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer. A short review.
Anticancer Res,
2010
;30(7):2943-2947.
[PubMed] [Full Article]
PJ McLaughlin, M Rogosnitzky and IS Zagon.
Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
Exp Biol Med (Maywood),
2010
;235(11): 1292-99.
[PubMed]
Zagon I, Donahue RN, Rogosnitzky M, McLaughlin PJ.
Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function.
Exp Biol Med (Maywood),
2008
;233: 968-979.
[PubMed]
Barken I, Geller J, Rogosnitzky M.
Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
Anticancer Res,
2008
;28(6A):3701-3704.
[PubMed] [Full Article]
Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.
Low-dose naltrexone therapy improves active Crohn's disease.
Am J Gastroenterol,
2007
;102(4):820-8.
[PubMed]
Hurst WJ, M Rogosnitzky, PJ McLaughlin, and IS Zagon.
The stability of opioid growth factor ([Met5]-enkephalin) in solution using HPLC and photodiode array detection.
J. Liquid Chromatography & Related Technologies,
2006
;29:1-7.
[Journal]
Book Chapters
Moshe Rogosnitzky and Rachel Danks
Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions
Advances in Cancer Management,
2012
;ISBN: 978-953-307-870-0.
Abstracts
Moshe Rogosnitzky, Carol A Bienstock, Yitzchak Issakov, Aaron Frenkel
Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of UserReported Outcomes
ISVER Conference Proceedings,
2016
[PDF]
T. Armaghany, G. Vahdati, S. Broline, R. Goshen, M. Rogosnitzky, E. Delpassand
Dramatic response with peptide receptor radionuclide therapy with 177Lu-DOTATATE and capecitabine in the treatment of metastatic thymic carcinoma
Journal of Nuclear Medicine,
2015
;56 no. Supplement 2 2A-30.
[Journal]
Raynaud, Kevin, Benoit Voisin, Dine Koriche, Moshe Rogosnitzky, Fabienne Saulnier, François-René Pruvot, Jean-Pierre Chambon, and Philippe Zerbib.
Sa1953 Severe Gastric Caustic Injuries (SGCI)-Conservative Management During Acute Phase Leads to Superior Long-Term Quality of Life (QOL) and Nutritional Outcome.
Gastroenterology,
;144, no. 5 (2013): S-343.